Switching From Risperidone Long Acting Injection (Consta) to Paliperidone Palmitate (Sustenna) in Patients With Schizophrenia and Its Influence on Subjective Well-Being: A Prospective Observational Study
Phase of Trial: Phase IV
Latest Information Update: 11 Dec 2015
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 07 Dec 2015 Status changed from recruiting to completedas reported by ClinicalTrials.gov.
- 12 Apr 2013 Planned End Date changed from 1 Dec 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 16 Oct 2012 New trial record